Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma

European Journal of Radiology

Volumn 75, Issue 1, 2010, Pages 91-97

  Luo, Wen ^a,b   Numata, Kazushi ^a   Morimoto, Manabu ^a   Oshima, Takashi ^a   Ueda, Michio ^a   Okada, Masahiro ^c   Takebayashi, Shigeo ^a   Zhou, Xiaodong ^b   Tanaka, Katsuaki ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast agent; Hepatocellular carcinoma; Radiofrequency ablation; Three dimensional computed tomography; Three dimensional ultrasonography

Indexed keywords

COMPUTED TOMOGRAPHY; CONTRAST AGENT; HEPATOCELLULAR CARCINOMA; RADIO-FREQUENCY ABLATION; THREE-DIMENSIONAL ULTRASONOGRAPHY;

ABLATION; COMPUTERIZED TOMOGRAPHY; TUMORS; ULTRASONIC IMAGING; ULTRASONOGRAPHY;

THREE DIMENSIONAL;

PERFLUBUTANE;

ACCURACY; ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL EVALUATION; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE RECONSTRUCTION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; THERAPY EFFECT; THREE DIMENSIONAL IMAGING; TUMOR ABLATION;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; FEMALE; FERRIC COMPOUNDS; HEPATECTOMY; HUMANS; IMAGING, THREE-DIMENSIONAL; IRON; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXIDES; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 77954089753     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.03.021     Document Type: Article

References (31)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: globocan 2000. Int J Cancer 94 (2001) 153-156
2. Lau W.Y., and Lai E.C. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7 (2008) 237-257
3. El-Serag H.B., Marrero J.A., Rudolph L., and Reddy K.R. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134 (2008) 1752-1763
4. Veltri A., Moretto P., Doriguzzi A., Pagano E., Carrara G., and Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16 (2006) 661-669
5. Howard J.H., Tzeng C.W., Smith J.K., et al. Radiofrequency ablation for unresectable tumors of the liver. Am Surg 74 (2008) 594-600
6. Crocetti L., and Lencioni R. Thermal ablation of hepatocellular carcinoma. Cancer Imaging 8 (2008) 19-26
7. Dietrich C.F. 3D real time contrast enhanced ultrasonography-a new technique. Rofo 174 (2002) 160-163
8. Ohto M., Kato H., Tsujii H., Maruyama H., Matsutani S., and Yamagata H. Vascular flow patterns of hepatic tumors in contrast-enhanced 3-dimensional fusion ultrasonography using plane shift and opacity control modes. J Ultrasound Med 24 (2005) 49-57
9. Luo W, Numata K, Morimoto M, et al. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions. Eur J Radiol. doi:10.1016/j.ejrad.2008.09.003 [accessed on October 17, 2008]
10. Numata K., Morimoto M., Ogura T., et al. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med 27 (2008) 395-406
11. Hatanaka K., Kudo M., Minami Y., et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 51 S1 (2008) 61-69
12. Nakano H., Ishida Y., Hatakeyama T., et al. Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases. World J Gastroenterol 14 (2008) 3207-3211
13. Edey A.J., Ryan S.M., Beese R.C., Gordon P., and Sidhu P.S. Ultrasound imaging of liver metastases in the delayed parenchymal phase following administration of Sonazoid using a destructive mode technique (Agent Detection Imaging). Clin Radiol 63 (2008) 1112-1120
14. Buscarini E., Savoia A., Brambilla G., et al. Radiofrequency thermal ablation of liver tumors. Eur Radiol 15 (2005) 884-894
15. Schima W., Ba-Ssalamah A., Kurtaran A., Schindl M., and Gruenberger T. Post-treatment imaging of liver tumours. Cancer Imaging 7 (2007) 28-36
16. Nakazawa T., Kokubu S., Shibuya A., et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188 (2007) 480-488
17. McGahan J.P., and Khatri V.P. Imaging findings after liver resection by using radiofrequency parenchymal coagulation devices: initial experiences. Radiology 247 (2008) 896-902
18. Ding H., Kudo M., Onda H., et al. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 221 (2001) 721-730
19. Tsuda M., Majima K., and Yamada T. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment. Clin Imaging 25 (2001) 409-415
20. Fujioka C., Horiguchi J., Ishifuro M., et al. A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT. Acad Radiol 13 (2006) 986-994
21. Lim H.S., Jeong Y.Y., Kang H.K., Kim J.K., and Park J.G. Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation. AJR Am J Roentgenol 187 (2006) W341-W349
22. Geyik S., Akhan O., Abbasoǧlu O., et al. Radiofrequency ablation of unresectable hepatic tumors. Diagn Interv Radiol 12 (2006) 195-200
23. Goldberg S.N., Gazelle G.S., and Mueller P.R. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 174 (2000) 323-331
24. Dill-Macky M.J., Asch M., Burns P., and Wilson S. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. AJR Am J Roentgenol 186 (2006) S287-S295
25. Filippone A., Iezzi R., Di Fabio F., Cianci R., Grassedonio E., and Storto M.L. Multidetector-row computed tomography of focal liver lesions treated by radiofrequency ablation: spectrum of findings at long-term follow-up. J Comput Assist Tomogr 31 (2007) 42-52
26. Choi D., Lim H.K., Lee W.J., et al. Radiofrequency ablation of liver cancer: early evaluation of therapeutic response with contrast-enhanced ultrasonography. Korean J Radiol 5 (2004) 185-198
27. Kim C.K., Choi D., Lim H.K., et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 56 (2005) 66-73
28. Vilana R., Bianchi L., Varela M., et al. Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?. Eur Radiol 16 (2006) 2454-2462
29. Wen Y.L., Kudo M., Zheng R.Q., et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 181 (2003) 57-63
30. Endo I., Shimada H., Sugita M., et al. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma. Surgery 142 (2007) 666-675
31. Dong Q., Xu W., Jiang B., et al. Clinical applications of computerized tomography 3-D reconstruction imaging for diagnosis and surgery in children with large liver tumors or tumors at the hepatic hilum. Pediatr Surg Int 23 (2007) 1045-1050